Prevalence and risk factors of hypertension in Myanmar: A systematic review and meta-analysis

Medicine (United States)

Volumn 93, Issue 21, 2014, Pages

  Naing, Cho ^a   Aung, Kyan ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADOLESCENT; ADULT; AWARENESS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MYANMAR; OBSERVATIONAL STUDY; PREVALENCE; PRIMARY MEDICAL CARE; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC); WORLD HEALTH ORGANIZATION; AGED; BLOOD PRESSURE MEASUREMENT; DISEASE MANAGEMENT; HEALTH SERVICE; META ANALYSIS; PRIMARY HEALTH CARE; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE DETERMINATION; DISEASE MANAGEMENT; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYPERTENSION; MALE; MYANMAR; OBSERVATIONAL STUDY AS TOPIC; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 84916603927     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000100     Document Type: Review

References (32)

1. Whelton PK, He J, Appel LJ,et al. National high blood pressure education program coordinating committee. primary prevention of hypertension: clinical and public health advisory from the national high blood pressure education program. JAMA. 2002;288:1882-1888.
2. James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520.
3. WHO. World Health Statistics. Geneva, Switzerland. 2012. http://www.who.int/gho/publications/world-health-statistics/EN-WHS2012-Full.pdf. Accessed May 27, 2014.
4. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260.
5. WHO. A Global Brief on Hypertension. Silent Killer, Global Public Health Crisis. Geneva, Switzerland. 2013. http://www.who.int/cardiovascular-diseases/publications/global-brief-hypertension/en/.Accessed April 7, 2014.
6. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
7. WHO. Noncommunicable Disease Risk Factor Survey Myanmar 2009. SEA-Tobacco-40. WHO/SERO. 2011. http://www.searo.who.int/entity/noncommunicable-diseases/data/mmr-2009-steps-survey-report.pdf. Accessed May 27, 2014.
8. Picon RV, Fuchs FD, Moreira LB, et al. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One. 2012;7:e48255.
9. Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107:224-233.
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6:e1000097.
11. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560-2572.
12. World Health Organization. Arterial Hypertension Report of Expert Committee. Technical Report Series No. 628. Geneva, Switzerland: WHO; 1978.
13. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
15. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). London, UK: The Cochrane Collaboration; 2011:277-279,420.
16. Htoon MT, Ngwe T, Tun N, Kyaw MM. Prevalence of cardiovascular diseases in rural area of Hmawbi and urban Yangon city. Asia Pac J Public Health. 1992;6:188-194.
17. Shwe S, Ohnmar, Than K-K, et al. Prevalence of hypertension in two selected villages of Kayin state, Myanmar. Reg Health Forum. 2004;8:104-112.
18. WHO. STEPwise Approach to Chronic Disease Risk Factor Surveillance. WHO. STEPS Survey Report-urban and 2004 STEPS Survey Report- rural. 2004. http://www.who.int/chp/steps/myanmar/en/. Accessed April 7, 2014.
19. Win H, Thu A, Tun KM, et al. Prevalence, awareness, correlates, treatment and control of hypertension in a rural community of Waw Township, Bago Division. Myanmar Health Sci Res J. 2006;18:41-46.
20. Moe H. Blood Pressure Changes in Elderly People in Mandalay [master's thesis]. Mandalay, Myanmar: University of Medicine; 2007.
21. Zaw KK, Latt TS, Aung PP, et al. Prevalence of hypertension and its associated factors in the adult population in Yangon division, Myanmar. Asia Pac J Public Health. 2011;23:496-506.
22. Taleb MA, Rahman S, Acharyya A, et al. Prevalence of hypertension among Bangladeshi adults population: a meta-analysis. Reg Health Forum. 2013;17:15-18.
23. Anchala R, Kannuri NK, Pant H, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014; 32:1170-1177.
24. Ma YQ, Mei WH, Yin P, et al. Prevalence of hypertension in Chinese cities: a meta-analysis of published studies. PLoS One. 2013;8:e58302.
25. Kearney PM, Whelton M, Reynolds K, et al. Worldwide of hypertension: a systematic review. J Hypertens. 2004;22:11-19.
26. Rizwan SA, Kumar R, Singh AK, et al. Prevalence of hypertension in Indian tribes: a systematic review and meta-analysis of observational studies. PLoS One. 2014;9:e95896.
27. Tibazarwa KB, Damasceno AA. Hypertension in developing countries. Can J Cardiol. 2014;30:527-533.
28. Midgley J, Mathew A, Greenwood C, Logan A. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomised controlled trials. JAMA. 1996;275:1590-1597.
29. He F, MacGregor G. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761-770.
30. Heart Foundation. Salt and Hypertension. 2013. http://www.heartfoundation.org.au/SiteCollectionDocuments/Nut-Salt-Hypertension.pdf. Accessed May 27, 2014.
31. Zuo H, Shi Z, Hussain A. Prevalence, trends and risk factors for the diabetes epidemic in China: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2014;104:63-72.
32. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. 2011. http://www.ncbi.nlm.nih.gov/pubmed/22855971.